Terns Pharmaceuticals, Inc.(TERN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TERN Terns Pharmaceuticals, Inc.

Pre-Mkt 04-10 04:23:19 EDT

52.56

-0.10

-0.19%

盘前52.00

-0.56-1.07%

04:01 EDT

High52.67	Low52.56	Vol11.83M
Open52.65	D1 Closing52.66	Amplitude0.21%
Mkt Cap6.07B	Tradable Cap5.94B	Total Shares115.41M
T/O622.10M	T/O Rate10.47%	Tradable Shares113.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TERN","market":"US","secType":"STK","nameCN":"Terns Pharmaceuticals, Inc.","latestPrice":52.56,"timestamp":1775764800000,"preClose":52.66,"halted":0,"volume":11827350,"hourTrading":{"tag":"盘前","latestPrice":52,"preClose":52.56,"latestTime":"04:01 EDT","volume":192,"amount":9984,"timestamp":1775808074435,"change":-0.56,"changeRate":-0.010654,"amplitude":0},"delay":0,"changeRate":-0.001898974553740872,"floatShares":112999999,"shares":115413392,"eps":-1.031852,"marketStatus":"Pre-Mkt","change":-0.1,"latestTime":"04-10 04:23:19 EDT","open":52.65,"high":52.67,"low":52.56,"amount":622103979.56805,"amplitude":0.002089,"askPrice":52.54,"askSize":107,"bidPrice":52.3,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.031852,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1775827800000},"marketStatusCode":1,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":52.56,"preHourTrading":{"tag":"盘前","latestPrice":52,"preClose":52.56,"latestTime":"04:01 EDT","volume":192,"amount":9984,"timestamp":1775808074435,"change":-0.56,"changeRate":-0.010654,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":52.56,"preClose":52.56,"latestTime":"18:21 EDT","volume":1023268,"amount":53783022.42,"timestamp":1775773292281,"change":0,"changeRate":0,"amplitude":0.001522},"volumeRatio":0.8733023445254696,"impliedVol":0.0797,"impliedVolPercentile":0.0161},"requestUrl":"/m/hq/s/TERN","defaultTab":"news","newsList":[{"id":"2626929782","title":"Merck & Co Inc Stock (MRK) Moved Up by 3.18% on Apr 8: Facts Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626929782","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626929782?lang=en_us&edition=fundamental","pubTime":"2026-04-09 02:15","pubTimestamp":1775672130,"startTime":"0","endTime":"0","summary":"• Enlicitide Phase 3 results show significant LDL reduction and safety.\n• Keytruda approved in EU for platinum-resistant ovarian cancer.\n• Merck acquired Terns Pharmaceuticals to strengthen pipeline.","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/Market-Movers/261763057-market-movers-mrk-20260408","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0689472784.USD","LU2237443549.SGD","LU1699723380.USD","ELIS","SGXZ81514606.USD","IE00BVYPNW00.USD","LU1267930813.SGD","SG9999014567.USD","LLII","LLY","BK4599","LU2108987350.USD","LU0385154629.USD","LU0266013472.USD","BK4559","LU2896262040.SGD","LU0345769128.USD","MRK","LU0130517989.USD","LU0683600562.USD","IE00B775H168.HKD","LLYZ","LU1035775433.USD","IE0005OL40V9.USD","LU1894683348.USD","LU1023059063.AUD","JNJ","LLYX","LU0861579265.USD","LU2236285917.USD","LU0109394709.USD","LU2271345857.HKD","LU1934455194.USD","LU0345769631.USD","LU1116320901.HKD","TERN.AU","LU2265009873.SGD","LU2552382058.USD","LU0820562030.AUD","LU1196500208.SGD","LU0225283273.USD","LU1804176565.USD","LU2129689431.USD","TERN","LU1145028129.USD","SG9999018857.SGD","LU1064131342.USD","LU1037948897.HKD","ELIL","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625942352","title":"Terns Pharmaceuticals Inc : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $53 From $58","url":"https://stock-news.laohu8.com/highlight/detail?id=2625942352","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625942352?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:33","pubTimestamp":1775655188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40R177:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","BK4007","LU0109394709.USD","LU0320765992.SGD","TERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625484829","title":"Terns Pharmaceuticals Inc : William Blair Cuts to Market Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2625484829","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625484829?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:50","pubTimestamp":1775645451,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nFWN40R0XS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TERN","BK4007","LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625627968","title":"William Blair Downgrades Terns Pharmaceuticals to Market Perform From Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2625627968","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625627968?lang=en_us&edition=fundamental","pubTime":"2026-04-08 02:19","pubTimestamp":1775585978,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals (TERN) has an average rating of overweight and mean price target of $54.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625957603","title":"Analysts Offer Insights on Healthcare Companies: Plus Therapeutics (PSTV) and Terns Pharmaceuticals (TERN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625957603","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625957603?lang=en_us&edition=fundamental","pubTime":"2026-04-08 00:40","pubTimestamp":1775580042,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Plus Therapeutics (PSTV) and Terns Pharmaceuticals (TERN). Plus T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-plus-therapeutics-pstv-and-terns-pharmaceuticals-tern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-plus-therapeutics-pstv-and-terns-pharmaceuticals-tern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4007","BK4581","LABU","LU0109394709.USD","BK4139","LU0320765992.SGD","BK4137","LU0889565916.HKD","XLV","TERN","PSTV","LU0029874061.USD","HCSG","LU0128526141.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625395792","title":"Terns Pharmaceuticals downgraded to Market Perform from Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2625395792","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625395792?lang=en_us&edition=fundamental","pubTime":"2026-04-08 00:40","pubTimestamp":1775580014,"startTime":"0","endTime":"0","summary":"William Blair downgraded Terns Pharmaceuticals (TERN) to Market Perform from Outperform. Following Terns’ filing of its Schedule 14D-9 solicitation...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/terns-pharmaceuticals-downgraded-to-market-perform-from-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/terns-pharmaceuticals-downgraded-to-market-perform-from-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625954308","title":"Unusually active option classes on open April 7th","url":"https://stock-news.laohu8.com/highlight/detail?id=2625954308","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625954308?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:03","pubTimestamp":1775574235,"startTime":"0","endTime":"0","summary":"Unusual total active option classes on open include: Virgin Galactic (SPCE), Invesco (IVZ), Terns Parmaceuticles (TERN), UnitedHealth (UNH), Sealsq...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-april-7th-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unusually-active-option-classes-on-open-april-7th-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","LU0029864427.USD","LU0528227936.USD","LU1854103824.USD","LU0553294199.USD","LU2089284900.SGD","LU0058720904.USD","LU2244417387.USD","LU0354030438.USD","LU1551013342.USD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999014914.USD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU0432979614.USD","IE00B19Z9Z06.USD","LU0823416689.USD","LU1720051108.HKD","LU2111349929.HKD","IE00B19Z9P08.USD","LU0320765059.SGD","UNHG","LU0114720955.EUR","IE00BGHQF748.EUR","LU0354030511.USD","BK4534","LU0122379950.USD","LU1674673691.USD","LU0672654240.SGD","LU1066053197.SGD","LU1267930573.SGD","LU0496365809.HKD","LU0943347566.SGD","LU1003077747.HKD","LU1069347547.HKD","LU0965508806.USD","IE00B7SZLL34.SGD","LU0345770308.USD","LU0353189680.USD","BK4585","LU0107464264.USD","IE0004445015.USD","LU0187121727.USD","LU1732800096.USD","LU0353189763.USD","IE00BN29S564.USD","LU0965509283.SGD","LU1037948541.HKD","LU0109391861.USD","BK4581","IE00BJJMRZ35.SGD","IE00B775H168.HKD","LU0149725797.USD","LU0949170772.SGD","LU1074936037.SGD","LU0211327993.USD","BK4566","BK4154","IE0004445239.USD","IE0005OL40V9.USD","LU2362541273.HKD","LU1267930227.SGD","LU2491050071.SGD","LU2552382215.SGD","SGXZ81514606.USD","IE00BZ1G4Q59.USD","LU2023251221.USD","LU1496350502.SGD","SG9999013999.USD","IE00B19Z8X17.USD","LU2112291526.USD","IE00B2B36J28.USD","BK4564","IE00BFXG1179.USD","IE00BKPKM429.USD","LU0342679015.USD","LU0708995401.HKD","LU1261432733.SGD","SG9999001176.SGD","LU1934455277.USD","IE0002141913.USD","SG9999002224.SGD","LU0094547139.USD","LU0077335932.USD","LU0545039389.USD","LU2491050154.USD","IE000M9KFDE8.USD","LU1506573853.SGD","SG9999018857.SGD","LU1037948897.HKD","LU1934455194.USD","LU1934455863.HKD","LU0048584097.USD","LU1084165304.USD","TERN","LU1732799900.SGD","LU0456855351.SGD","LU2242649171.HKD","LU0976567544.SGD","LU1064131342.USD","LU2089984988.USD","IE00B4R5TH58.HKD","SG9999001176.USD","SG9999002232.USD","LU1061106388.HKD","LU2271345857.HKD","LU0683600562.USD","LU0820561909.HKD","SG9999014898.SGD","BK4187","LU2362541513.USD","IE00BSNM7G36.USD","LU0128525689.USD","IVZ","LU0861579265.USD","LU2552382058.USD","LU0198837287.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","SG9999014906.USD","UNH","IE00BJJMRX11.SGD","LU0795875169.SGD","LU0211326839.USD","LU0912757837.SGD","LU1035773651.USD","BK4588","LU0689472784.USD","SGXZ57979304.SGD","BK4135","BK4562","IE00B3QW5Z07.USD","LU0203345920.USD","LU2361044865.SGD","IE00B19Z8W00.USD","IE00B19Z3B42.SGD","LU2089283258.USD","LU0882574055.USD","UNHW","LU1914381329.SGD","LU1066051811.HKD","LU2362540622.SGD","SGXZ99366536.SGD","LU1854104046.USD","LU0211326755.USD","LU2361045086.USD","LU0708994859.HKD","IE00B19Z3581.USD","LU0310799852.SGD","LU0079474960.USD","LU1670628061.USD","LU2133065610.SGD","LU1153585028.USD","LU0158827781.USD","LU1066051225.USD","LU1720051017.SGD","LU0097036916.USD","SG9999014880.SGD","LU0661504455.SGD","LU1778281490.HKD","LU1989771016.USD","IE00B4JS1V06.HKD","LU0965509101.SGD","SGXZ31699556.SGD","LU1551013425.SGD","LU2264538146.SGD","LU0889565916.HKD","LU2347655156.SGD","LU1718418525.SGD","LU2324357040.USD","LU0109394709.USD","LU2236285917.USD","BK4532","IE0002270589.USD","IE00BZ9MQY76.HKD","LU0128525929.USD","LU0158827948.USD","LU0965509010.AUD","LU1291159041.SGD","LU2468319806.SGD","LU0738911758.USD","SGXZ51526630.SGD","LAES","LU1267930730.SGD","LU1548497426.USD","LU0052756011.USD","SPCE","LU2552382132.HKD","LU0256863811.USD","LU0795875086.SGD","IE00BFSS8Q28.SGD","LU1023059063.AUD","LU1983299246.USD","LU2211815571.USD","LU1267930490.SGD","LU0820562030.AUD","LU2491049909.HKD","LU1988902786.USD","LU0316494557.USD","IE00B7KXQ091.USD","IE0009355771.USD","LU0820561818.USD","LU2028103732.USD","SG9999017495.SGD","LU1814569148.SGD","LU2125154935.USD","BK4533","LU1066051498.USD","LU2279689827.SGD","LU0203347892.USD","LU0557290698.USD","LU2357305700.SGD","LU1791710400.SGD","LU0234572021.USD","LU0266013472.USD","LU2087625088.SGD","LU1674673428.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU1119994496.HKD","LU1323610961.USD","LU0320765992.SGD","LU1670627923.USD","LU2360032135.SGD","LU1791710582.SGD","LU0251132253.USD","LU0053666078.USD","LU0787776722.HKD","IE00BFSS7M15.SGD","IE00B19Z9505.USD","LU0011850046.USD","BK4007","IE00BWXC8680.SGD","LU0417517546.SGD","LU0289739699.SGD","IE00B894F039.SGD","LU2361044949.HKD","LU0211328371.USD","LU0310800379.SGD","LU0310800965.SGD","LU0345770993.USD","LU2125154778.USD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625956488","title":"Merck begins tender offer to acquire Terns Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2625956488","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625956488?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:50","pubTimestamp":1775569837,"startTime":"0","endTime":"0","summary":"Merck (MRK) is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/merck-begins-tender-offer-to-acquire-terns-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/merck-begins-tender-offer-to-acquire-terns-pharmaceuticals-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0238689110.USD","LU1066051498.USD","LU1917777945.USD","LU1430594728.SGD","LU1989771016.USD","LU2125154778.USD","LU1929549753.HKD","LU0980610538.SGD","LU1989772923.USD","LU0265550946.USD","LU1023059063.AUD","LU2125154935.USD","LU1571399168.USD","IE000M9KFDE8.USD","BK4534","LU1066051811.HKD","SG9999014575.USD","LU0477156953.USD","LU0203345920.USD","LU1037948541.HKD","LU1066053197.SGD","IE00BSNM7G36.USD","IE00BLSP4239.USD","SG9999014542.SGD","IE00BJT1NW94.SGD","IE00BN8TJ469.HKD","LU2112291526.USD","BK4559","LU0098860793.USD","LU0889565916.HKD","IE00BLSP4452.SGD","LU2023250504.SGD","LU0965509010.AUD","LU0868494708.USD","LU2461242641.AUD","SGXZ57979304.SGD","BK4588","IE00B1BXHZ80.USD","LU0320765646.SGD","LU0868494617.USD","LU1699723380.USD","IE0009355771.USD","SG9999001440.SGD","LU1061106388.HKD","LU0320765489.SGD","LU1057294990.SGD","LU2360032135.SGD","LU1983299246.USD","BK4585","LU0965509283.SGD","LU2324357040.USD","SG9999015341.SGD","LU0432979614.USD","LU0965509101.SGD","LU0265550359.USD","LU0320765992.SGD","LU0006306889.USD","SG9999014559.SGD","BK4550","LU1116320737.USD","SG9999001176.SGD","LU0109394709.USD","LU1941712264.USD","IE00BBT3K403.USD","IE00BFTCPJ56.SGD","LU1037948897.HKD","LU1974910355.USD","LU1934455277.USD","LU2023250843.SGD","IE00BJJMRZ35.SGD","LU1162221912.USD","LU1201861249.SGD","SG9999015358.SGD","LU0070302665.USD","LU0289739699.SGD","LU0058720904.USD","SG9999001176.USD","LU0861579265.USD","LU0965508806.USD","LU1035773651.USD","LU2089984988.USD","LU0648001328.SGD","BK4533","LU0106261372.USD","MRK","LU1093756168.USD","LU1069347547.HKD","IE00B2B36J28.USD","LU1989772840.SGD","LU1941712348.USD","LU0211331839.USD","LU1116320901.HKD","LU0122379950.USD","LU0266013472.USD","SG9999002232.USD","LU1585245621.USD","IE0002141913.USD","SG9999013999.USD","LU2361045086.USD","LU2468319806.SGD","BK4007","LU0985320562.USD","LU2361044949.HKD","LU0942090050.USD","LU1291159041.SGD","LU1093756325.SGD","LU2361044865.SGD","TERN","LU2106854487.HKD","LU1066051225.USD","SG9999014567.USD","SG9999002224.SGD","LU1934455194.USD","IE00B4R5TH58.HKD","LU0208291251.USD","LU0130102774.USD","LU0203347892.USD","LU1934455863.HKD","LU0130517989.USD","LU0234572021.USD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625953222","title":"BRIEF-Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2625953222","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625953222?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:03","pubTimestamp":1775566982,"startTime":"0","endTime":"0","summary":"BRIEF-Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.April 7 (Reuters) - Merck & Co Inc MRK.N:MERCK BEGINS TENDER OFFER TO ACQUIRE TERNS PHARMACEUTICALS, INC.MERCK BEGINS TENDER OFFER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA6G9H8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4007","IE00BJT1NW94.SGD","LU0070302665.USD","LU2089984988.USD","LU1023059063.AUD","LU0234572021.USD","LU0208291251.USD","LU1057294990.SGD","SG9999014542.SGD","LU1066051498.USD","SG9999014575.USD","SG9999001176.USD","LU2361044949.HKD","LU1061106388.HKD","SG9999001440.SGD","BK4550","TERN","LU0058720904.USD","LU1066051225.USD","LU2023250504.SGD","IE0009355771.USD","LU1037948897.HKD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU0320765646.SGD","LU1941712348.USD","LU1983299246.USD","LU0320765489.SGD","LU1116320737.USD","LU1974910355.USD","LU1037948541.HKD","IE00B4R5TH58.HKD","LU1989772923.USD","LU0477156953.USD","LU2461242641.AUD","LU0965508806.USD","LU0985320562.USD","SG9999015358.SGD","BK4585","LU0965509010.AUD","LU0868494708.USD","LU0320765992.SGD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU0130517989.USD","LU2361045086.USD","BK4559","LU0965509101.SGD","SGXZ57979304.SGD","LU2125154778.USD","LU1929549753.HKD","LU0122379950.USD","BK4533","LU0238689110.USD","SG9999014567.USD","LU1162221912.USD","LU1093756168.USD","SG9999015341.SGD","LU0203347892.USD","LU1941712264.USD","LU0889565916.HKD","LU0211331839.USD","SG9999001176.SGD","SG9999013999.USD","LU1917777945.USD","IE00B2B36J28.USD","LU0098860793.USD","LU1201861249.SGD","LU2360032135.SGD","SG9999002232.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU2106854487.HKD","LU0861579265.USD","BK4516","LU2468319806.SGD","IE00B1BXHZ80.USD","LU2361044865.SGD","LU1699723380.USD","LU1066051811.HKD","LU1291159041.SGD","IE000M9KFDE8.USD","LU1934455863.HKD","MRK","LU2112291526.USD","LU0109394709.USD","IE00BLSP4452.SGD","LU2125154935.USD","LU1585245621.USD","LU0006306889.USD","LU1093756325.SGD","LU1116320901.HKD","LU0266013472.USD","LU2324357040.USD","LU1989772840.SGD","LU0942090050.USD","LU1035773651.USD","LU1571399168.USD","LU1069347547.HKD","LU0965509283.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999014559.SGD","BK4588","LU2023250843.SGD","LU0980610538.SGD","LU0265550359.USD","IE00BLSP4239.USD","IE0002141913.USD","LU0432979614.USD","LU0648001328.SGD","LU0868494617.USD","LU1934455194.USD","LU0106261372.USD","LU1934455277.USD","LU1989771016.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625095389","title":"Merck’s US$6.7b Terns Deal And What It Means For Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2625095389","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625095389?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:37","pubTimestamp":1775561823,"startTime":"0","endTime":"0","summary":"Merck (NYSE:MRK) is acquiring Terns Pharmaceuticals in a $6.7b deal, one of the largest biopharma M&A transactions announced so far in 2026.\nThe transaction is centered on expanding Merck's oncology and hematology pipeline with Terns' early and mid stage cancer assets.\nThe move aligns with Merck's effort to address upcoming patent expiries and broaden its portfolio beyond its Keytruda franchise.\n\nFor investors tracking NYSE:MRK, this deal lands at a time when the stock trades around $120.85...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/288502-main-header/1756255043815"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/mercks-us67b-terns-deal-and-what-it-means-for-valuation","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/mercks-us67b-terns-deal-and-what-it-means-for-valuation","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4534","BK4007","IE00BJT1NW94.SGD","LU0070302665.USD","LU2089984988.USD","LU1023059063.AUD","LU0234572021.USD","LU0208291251.USD","LU1057294990.SGD","SG9999014542.SGD","LU1066051498.USD","SG9999014575.USD","SG9999001176.USD","LU2361044949.HKD","LU1061106388.HKD","SG9999001440.SGD","BK4550","TERN","LU0058720904.USD","LU1066051225.USD","LU2023250504.SGD","IE0009355771.USD","LU1037948897.HKD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU0320765646.SGD","LU1941712348.USD","LU1983299246.USD","LU0320765489.SGD","LU1116320737.USD","LU1974910355.USD","LU1037948541.HKD","IE00B4R5TH58.HKD","LU1989772923.USD","LU0477156953.USD","LU2461242641.AUD","LU0965508806.USD","LU0985320562.USD","SG9999015358.SGD","BK4585","LU0965509010.AUD","LU0868494708.USD","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU0265550946.USD","LU0130517989.USD","LU2361045086.USD","BK4559","LU0965509101.SGD","SGXZ57979304.SGD","LU2125154778.USD","LU1929549753.HKD","LU0122379950.USD","BK4533","LU0238689110.USD","SG9999014567.USD","LU1162221912.USD","LU1093756168.USD","SG9999015341.SGD","LU0203347892.USD","LU1941712264.USD","LU0211331839.USD","SG9999001176.SGD","SG9999013999.USD","LU1917777945.USD","IE00B2B36J28.USD","LU0098860793.USD","LU1201861249.SGD","LU2360032135.SGD","SG9999002232.USD","IE00BN8TJ469.HKD","LU0130102774.USD","LU2106854487.HKD","LU0861579265.USD","BK4516","LU2468319806.SGD","IE00B1BXHZ80.USD","LU2361044865.SGD","LU1699723380.USD","LU1066051811.HKD","LU1291159041.SGD","IE000M9KFDE8.USD","LU1934455863.HKD","MRK","LU2112291526.USD","IE00BLSP4452.SGD","LU2125154935.USD","LU1585245621.USD","LU0006306889.USD","LU1093756325.SGD","LU1116320901.HKD","LU0266013472.USD","LU2324357040.USD","LU1989772840.SGD","LU0942090050.USD","LU1035773651.USD","LU1571399168.USD","LU1069347547.HKD","LU0965509283.SGD","LU0289739699.SGD","SG9999002224.SGD","SG9999014559.SGD","BK4588","LU2023250843.SGD","LU0980610538.SGD","LU0265550359.USD","IE00BLSP4239.USD","IE0002141913.USD","LU0432979614.USD","LU0648001328.SGD","LU0868494617.USD","LU1934455194.USD","LU0106261372.USD","LU1934455277.USD","LU1989771016.USD","LU1066053197.SGD","IE00BBT3K403.USD","LU1430594728.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624669875","title":"The Trader: Biotechs Are a Healthy Growth Bet. Thank M&A and New Drugs. -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2624669875","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624669875?lang=en_us&edition=fundamental","pubTime":"2026-04-04 09:30","pubTimestamp":1775266200,"startTime":"0","endTime":"0","summary":"Big Pharma companies are constantly searching for the next hot new drugs -- and it's often a lot easier to buy them than develop them. That's great news for biotech investors. Merger activity is starting to heat up again in the sector.There were three notable deals in March alone. Biogen just announced a deal to buy Apellis Pharmaceuticals, a developer of immunological and rare-disease medications, for $5.6 billion, a takeover premium of nearly 140%. Mounjaro owner Eli Lilly is buying sleep-drug maker Centessa Pharmaceuticals for $7.8 billion. And Merck said it would buy Terns Pharmaceuticals, which is working on a drug to treat leukemia, for $6.7 billion.Mergers won't be the only catalyst for biotechs. Analysts at Cantor Fitzgerald pointed out in a report in March that they expect about 80% of the companies in the State Street SPDR S&P Biotech ETF will have approved drugs by the third quarter of next year. This, according to Cantor, suggests the industry is \"still early in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","IE00B64PRP62.GBP","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","BK4505","IE0034235188.USD","LU1983260115.SGD","ARGX","LU1093756168.USD","LU1883839398.USD","BK4539","LU1894683348.USD","LU0109394709.USD","IE00B3QW5Z07.USD","LU0061475181.USD","TERN","IE00BGHQF748.EUR","IE00B4R5TH58.HKD","BK4135","STT","IE0002141913.USD","LU0320765992.SGD","LU1894683264.USD","BK4007","LU0889565916.HKD","KALV","BK4588","CNTA","LU2324357040.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","APLS","BK4535","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624639228","title":"Top Executive’s Surprise Stock Move Shakes Up Terns Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2624639228","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624639228?lang=en_us&edition=fundamental","pubTime":"2026-04-03 10:02","pubTimestamp":1775181720,"startTime":"0","endTime":"0","summary":"New insider activity at Terns Pharmaceuticals ( ($TERN) ) has taken place on April 2, 2026. Terns Pharmaceuticals has disclosed that its Chief Medi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-surprise-stock-move-shakes-up-terns-pharmaceuticals-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-surprise-stock-move-shakes-up-terns-pharmaceuticals-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0109394709.USD","LU0320765992.SGD","TERN","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624840706","title":"Press Release: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624840706","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624840706?lang=en_us&edition=fundamental","pubTime":"2026-04-03 04:05","pubTimestamp":1775160300,"startTime":"0","endTime":"0","summary":"FOSTER CITY, Calif., April 02, 2026  -- Terns Pharmaceuticals, Inc.  , a clinical-stage oncology company, today announced that it has granted as of April 1, 2026 equity inducement awards to three new employees under the terms of the 2022 Employment Inducement Award Plan, as amended. The equity awards were approved by the Compensation Committee of the Company's Board of Directors in accordance with Nasdaq Listing Rule 5635 and were made as a material inducement to the employees' acceptance of employment with Terns.The Company granted 23,316 restricted stock units , in the aggregate, of Terns common stock to the new employees. The RSUs vest over four years, subject to the employees' continued service through the applicable vesting dates.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4504","LU2462157665.USD","LU2125154778.USD","NQmain","BK4007","LU0889565916.HKD","LU0072461881.USD","LU2360032135.SGD","CUL3","LU0052756011.USD","LU0098860793.USD","LU1267930227.SGD","LU0106831901.USD","LU0162691827.USD","BK4585","LU0980610538.SGD","LU0648001328.SGD","LU1366192091.USD","LU1791807156.HKD","LU1244550494.USD","LU2236285917.USD","LU0320765992.SGD","BK4207","LU1244550577.SGD","LU0310800965.SGD","LU1201861249.SGD","BK4559","LU1506573853.SGD","IE00BSNM7G36.USD","LU0314106906.USD","LU1668664300.SGD","LU0130517989.USD","BK4566","TERN","LU1162221912.USD","LU0170899867.USD","LU1244550221.USD","LU0320765646.SGD","LU2125154935.USD","LU0477156953.USD","LU0128525689.USD","BK4534","LU2456880835.USD","LU0109394709.USD","LU0130102774.USD","LU2417539215.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624767530","title":"Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2624767530","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624767530?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:36","pubTimestamp":1774989360,"startTime":"0","endTime":"0","summary":"Big Pharma companies are constantly searching for the next hot new drugs -- and it's often a lot easier to buy them than develop them. That's great news for biotech investors. Merger activity is starting to heat up again in the sector.There were three notable deals in March alone. Biogen just announced a deal to buy Apellis Pharmaceuticals, a developer of immunological and rare disease medications, for $5.6 billion, a takeover premium of nearly 140%. Mounjaro owner Eli Lilly is buying sleep drug maker Centessa Pharmaceuticals for $7.8 billion. And Merck said it would buy Terns Pharmaceuticals, which is working on a drug to treat leukemia, for $6.7 billion.Mergers won't be the only catalyst for biotechs. Analysts at Cantor pointed out in a report in March that they expect about 80% of the companies in the State Street SPDR S&P Biotech ETF will have approved drugs by the third quarter of next year. This, according to the Cantor analysts, suggests","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4535","CNTA","BK4585","LU1894683264.USD","BK4539","BK4505","IE0009355771.USD","IE00BGHQF748.EUR","IE0002141913.USD","LU1093756168.USD","BK4135","IE00B4R5TH58.HKD","LU0109394709.USD","ARGX","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0061475181.USD","LU1983260115.SGD","APLS","BK4007","TERN","LU0320765992.SGD","STT","IE00B3QW5Z07.USD","LU1093756325.SGD","LU2324357040.USD","KALV","LU1883839398.USD","BK4139","LU0889565916.HKD","BK4588","IE00B2B36J28.USD","IE00B64PRP62.GBP","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624532800","title":"Tern plc Confirms Updated Total Voting Rights and Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2624532800","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624532800?lang=en_us&edition=fundamental","pubTime":"2026-04-01 03:18","pubTimestamp":1774984684,"startTime":"0","endTime":"0","summary":"Tern plc ( ($GB:TERN) ) has provided an announcement. Tern plc has confirmed that its issued ordinary share capital now comprises 750,877,367 ordin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tern-plc-confirms-updated-total-voting-rights-and-share-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tern-plc-confirms-updated-total-voting-rights-and-share-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TERN","LU0320765992.SGD","LU0889565916.HKD","BK4007","TSS","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535337","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Galectin Therapeutics (GALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535337","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623535337?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:40","pubTimestamp":1774971609,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Terns Pharmaceuticals (TERN), Sangamo Therapeutics (SGMO) and Gal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-terns-pharmaceuticals-tern-sangamo-therapeutics-sgmo-and-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-terns-pharmaceuticals-tern-sangamo-therapeutics-sgmo-and-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4139","HCSG","LABU","BK4556","SGMO","BK4581","TERN","GALT","LU0320765992.SGD","BK4007","BK4137","BK4588","XBI","LU0029874061.USD","LU0109394709.USD","LU0889565916.HKD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623338825","title":"Terns Pharmaceuticals Cut to Hold From Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2623338825","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623338825?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:08","pubTimestamp":1774969680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TERN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2026 11:08 ET (15:08 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4007","LU0109394709.USD","LU0320765992.SGD","TERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623304652","title":"Barclays Keeps Their Hold Rating on Terns Pharmaceuticals (TERN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623304652","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623304652?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:28","pubTimestamp":1774945732,"startTime":"0","endTime":"0","summary":"Barclays analyst Etzer Darout maintained a Hold rating on Terns Pharmaceuticals today and set a price target of $53.00. Darout covers the Healthcar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-terns-pharmaceuticals-tern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-keeps-their-hold-rating-on-terns-pharmaceuticals-tern-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TERN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623311309","title":"U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, Starbucks","url":"https://stock-news.laohu8.com/highlight/detail?id=2623311309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623311309?lang=en_us&edition=fundamental","pubTime":"2026-03-31 15:39","pubTimestamp":1774942790,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Dutch Bros, Phreesia, StarbucksMarch 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Dutch Bros","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4N40J0NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVS","USGG","APH","ADP","ESAB","VRT","ANAB","VRTL","CMGG","VLTO","FLS","MKC","PHR","ABT","JACK","FRDD","TERN","USAR","PCTY","IE0034390439.USD","MMED","PAYC","PNW","SHAK","TMO","SBU","ETR","LU0965508806.USD","MSA","NRG","PRGS","LECO","XYL","USAX","ROK","VRDN","SG","FRDU","EMR","CAVA","CMG","MRK","LU1721427968.SGD","BROS","MAZE","MIDD","HAYW","WAB","SBUX","F"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623229943","title":"Analysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Aurinia Pharmaceuticals (AUPH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623229943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623229943?lang=en_us&edition=fundamental","pubTime":"2026-03-31 06:10","pubTimestamp":1774908607,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Terns Pharmaceuticals (TERN) and Aurinia Pharmaceuticals (AUPH). ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-terns-pharmaceuticals-tern-and-aurinia-pharmaceuticals-auph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-terns-pharmaceuticals-tern-and-aurinia-pharmaceuticals-auph-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","LU0889565916.HKD","TERN","LU0109394709.USD","LU0320765992.SGD","XLV","XBI","BK4007","BK4581","AUPH","BK4139","HCSG","BK4585","LU0128526141.USD","BK4588","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ternspharma.com","stockEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.1605},{"period":"3month","weight":0.4814},{"period":"6month","weight":5.4491},{"period":"1year","weight":21.8522},{"period":"ytd","weight":0.301}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of oncology, non-alcoholic steatohepatitis (NASH), and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in clinical development for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of NASH; and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for NASH and metabolic diseases, such as obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.15251},{"month":2,"riseRate":0.6,"avgChangeRate":0.020839},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.011585},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066108},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039095},{"month":6,"riseRate":0.6,"avgChangeRate":0.061446},{"month":7,"riseRate":0.4,"avgChangeRate":-0.000641},{"month":8,"riseRate":0.6,"avgChangeRate":0.306524},{"month":9,"riseRate":0.6,"avgChangeRate":0.082474},{"month":10,"riseRate":0.6,"avgChangeRate":0.010604},{"month":11,"riseRate":0.4,"avgChangeRate":0.415594},{"month":12,"riseRate":0.6,"avgChangeRate":0.20601}],"exchange":"NASDAQ","name":"Terns Pharmaceuticals, Inc.","nameEN":"Terns Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Terns Pharmaceuticals, Inc.(TERN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Terns Pharmaceuticals, Inc.(TERN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Terns Pharmaceuticals, Inc.,TERN,Terns Pharmaceuticals, Inc.股票,Terns Pharmaceuticals, Inc.股票老虎,Terns Pharmaceuticals, Inc.股票老虎国际,Terns Pharmaceuticals, Inc.行情,Terns Pharmaceuticals, Inc.股票行情,Terns Pharmaceuticals, Inc.股价,Terns Pharmaceuticals, Inc.股市,Terns Pharmaceuticals, Inc.股票价格,Terns Pharmaceuticals, Inc.股票交易,Terns Pharmaceuticals, Inc.股票购买,Terns Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Terns Pharmaceuticals, Inc.(TERN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Terns Pharmaceuticals, Inc.(TERN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction